Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 6:7:e20.
doi: 10.15420/cfr.2021.06. eCollection 2021 Mar.

Adjunctive Techniques for Repair of Ischaemic Mitral Regurgitation

Affiliations
Review

Adjunctive Techniques for Repair of Ischaemic Mitral Regurgitation

Sigrid L Johannesen et al. Card Fail Rev. .

Abstract

Ischaemic mitral regurgitation is a complex process with debate in the literature as to the optimal treatment pathway. Multiple therapies are available to alleviate mitral regurgitation including medical management, transcatheter edge-to-edge repair, mitral valve repair and mitral valve replacement. Medical management with goal-directed therapy should be utilised in patients with heart failure and mild-to-moderate regurgitation. Transcatheter approaches are typically used in patients with prohibitive operative risk, although their use is expanding, especially in those with functional mitral regurgitation who are not responding to goal-directed medical therapy. It is generally accepted that patients with mild-to-moderate disease can avoid valve intervention if successful revascularisation is performed. A higher consideration should be given to valve replacement over repair in patients with severe mitral regurgitation in the setting of myocardial ischaemia. Operative course must be personalised to each patient, and continues to develop with improving technologies and ongoing research into optimal treatment.

Keywords: Ischaemic mitral regurgitation; MitraClip; mitral regurgitation; mitral valve repair; mitral valve replacement; valvular heart disease.

PubMed Disclaimer

Conflict of interest statement

Disclosure: CMB receives research support from Abbott and Edwards. MML is a consultant for Boston Scientific. SLJ has no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Echocardiographic Images of Ischaemic Mitral Regurgitations

References

    1. Nkomo VT, Gardin JM, Skelton TN et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11. doi: 10.1016/S0140-6736(06)69208-8. - DOI - PubMed
    1. Amigoni M, Meris A, Thune JJ et al. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. Eur Heart J. 2007;28:326–33. doi: 10.1093/eurheartj/ehl464. - DOI - PubMed
    1. Nishimura RA, Otto CM, Bonow RO et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:2440–92. doi: 10.1161/CIR.0000000000000029. - DOI - PubMed
    1. Nishimura RA, Otto CM, Bonow RO et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;135:e1159–95. doi: 10.1161/CIR.0000000000000503. - DOI - PubMed
    1. Yancy CW, Jessup M, Bozkurt B et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;136:e137–61. doi: 10.1161/cir.0000000000000509. - DOI - PubMed

LinkOut - more resources